Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Allergan Inc's Groundhog Acquisition, Inc Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc

Friday, 1 Mar 2013 09:00am EST 

Allergan Inc announced the expiration of the tender offer initiated by wholly owned subsidiary, Groundhog Acquisition, Inc. (Purchaser), on January 31, 2013 to purchase all of the outstanding shares of common stock of MAP Pharmaceuticals, Inc. for $25.00 per share, net to the seller in cash, without interest and less any applicable withholding taxes, as set forth in the Tender Offer Statement on Schedule TO filed by Purchaser and Allergan with the U.S. Securities and Exchange Commission on January 31, 2013. The Offer and withdrawal rights expired at 12:00 midnight, New York City time, on the night of February 28, 2013. 

Company Quote

1.38 +0.62%
23 Jan 2015